Literature DB >> 15083751

Does systemic inflammation trigger local exercise-induced oxidative stress in COPD?

C Koechlin1, A Couillard, J P Cristol, P Chanez, M Hayot, D Le Gallais, C Préfaut.   

Abstract

Inflammatory abnormalities may be involved in the inadequate basal oxidant/antioxidant balance and local exercise-induced oxidative stress in chronic obstructive pulmonary disease (COPD) patients. The time course of oxidative stress and inflammation was investigated in 10 COPD patients and seven healthy subjects before and after local dynamic quadriceps endurance exercise at 40% of maximal strength. Venous samples were collected before, immediately after and up to 48 h after exercise. At rest, levels of an oxidant released by stimulated phagocytes, the superoxide anion, were significantly higher in patients, as were plasma levels of C-reactive protein, tumour necrosis factor-alpha and interleukin-6, inflammatory markers. An inverse relationship was found between baseline C-reactive protein levels and endurance time in patients. Six hours after exercise, superoxide anion release and levels of protein oxidation products, an index of oxidative stress, increased similarly in both groups, whereas thiobarbituric acid reactive substance levels, another index of oxidative stress, increased significantly only in patients. Plasma nonenzymatic antioxidant and inflammatory cytokine levels were unchanged by the exercise protocol. The increased baseline systemic inflammation in chronic obstructive pulmonary disease patients could be related to disturbed oxidant/antioxidant balance, and, together, these may have triggered the exercise-induced oxidative stress. The absence, however, of local exercise-induced systemic inflammation suggests that additional mechanisms explain local exercise-induced oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15083751     DOI: 10.1183/09031936.04.00069004

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  27 in total

Review 1.  Antioxidant pharmacological therapies for COPD.

Authors:  Irfan Rahman; William MacNee
Journal:  Curr Opin Pharmacol       Date:  2012-02-18       Impact factor: 5.547

Review 2.  Pharmacological antioxidant strategies as therapeutic interventions for COPD.

Authors:  Irfan Rahman
Journal:  Biochim Biophys Acta       Date:  2011-11-09

Review 3.  An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  François Maltais; Marc Decramer; Richard Casaburi; Esther Barreiro; Yan Burelle; Richard Debigaré; P N Richard Dekhuijzen; Frits Franssen; Ghislaine Gayan-Ramirez; Joaquim Gea; Harry R Gosker; Rik Gosselink; Maurice Hayot; Sabah N A Hussain; Wim Janssens; Micheal I Polkey; Josep Roca; Didier Saey; Annemie M W J Schols; Martijn A Spruit; Michael Steiner; Tanja Taivassalo; Thierry Troosters; Ioannis Vogiatzis; Peter D Wagner
Journal:  Am J Respir Crit Care Med       Date:  2014-05-01       Impact factor: 21.405

4.  Effects of rehabilitative exercise on peripheral muscle TNFalpha, IL-6, IGF-I and MyoD expression in patients with COPD.

Authors:  Ioannis Vogiatzis; Grigoris Stratakos; Davina C M Simoes; Gerasimos Terzis; Olga Georgiadou; Charis Roussos; Spyros Zakynthinos
Journal:  Thorax       Date:  2007-06-15       Impact factor: 9.139

Review 5.  Comorbidities in chronic obstructive pulmonary disease.

Authors:  Wissam M Chatila; Byron M Thomashow; Omar A Minai; Gerard J Criner; Barry J Make
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

6.  Quadriceps muscle strength in scoliosis.

Authors:  E B Swallow; E Barreiro; H Gosker; S A Sathyapala; F Sanchez; N S Hopkinson; J Moxham; A Schols; J Gea; M I Polkey
Journal:  Eur Respir J       Date:  2009-05-14       Impact factor: 16.671

7.  Reactive oxygen species in peripheral blood and sputum neutrophils during bacterial and nonbacterial acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Mindaugas Vaitkus; Simona Lavinskiene; Diana Barkauskiene; Kristina Bieksiene; Jolanta Jeroch; Raimundas Sakalauskas
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

Review 8.  Role of N-acetylcysteine in the management of COPD.

Authors:  Anna M Sadowska; J Verbraecken; K Darquennes; W A De Backer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

Review 9.  Oxidative stress and antioxidant defense mechanisms linked to exercise during cardiopulmonary and metabolic disorders.

Authors:  Kelsey Fisher-Wellman; Heather K Bell; Richard J Bloomer
Journal:  Oxid Med Cell Longev       Date:  2009 Jan-Mar       Impact factor: 6.543

Review 10.  Antioxidant therapies in COPD.

Authors:  Irfan Rahman
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.